David Mark Steinhaus
Director/Board Member at EBR SYSTEMS, INC.
Profile
David Mark Steinhaus is currently the Executive Chairman at Enopace Biomedical Ltd.
He is also an Independent Non-Executive Director at EBR Systems, Inc. and a Director at Qardio, Inc. Dr. Steinhaus previously worked as the VP & General Manager-Heart Failure Business at Cardiac Rhythm & Heart Failure.
He holds a doctorate degree from Harvard Medical School and an undergraduate degree from Harvard College.
David Mark Steinhaus active positions
Companies | Position | Start |
---|---|---|
EBR SYSTEMS, INC. | Director/Board Member | 2021-11-07 |
Enopace Biomedical Ltd.
Enopace Biomedical Ltd. Medical SpecialtiesHealth Technology Enopace Biomedical Ltd. develops medical devices to treat heart failure patients. The firm's technology consists of a minimally invasive, implantable neurostimulation device that increases cardiac efficiency by reducing left ventricular workload and improves the systolic/diastolic ratio. The company was by Yossi Gross and Amir Dagan in 2008 and is headquartered in Caesarea, Israel. | Chairman | - |
Qardio, Inc.
Qardio, Inc. Medical DistributorsDistribution Services Qardio, Inc. engages in the provision of wearable applications including heart monitoring devices to track health. It offers healthcare solutions for patients, doctors, and healthcare providers. The company was founded by Marco Peluso and Rosario Iannella in 2012 and is headquartered in San Francisco, CA. | Director/Board Member | 2022-08-09 |
Former positions of David Mark Steinhaus
Companies | Position | End |
---|---|---|
Cardiac Rhythm & Heart Failure | Corporate Officer/Principal | - |
Training of David Mark Steinhaus
Harvard Medical School | Doctorate Degree |
Harvard College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
EBR SYSTEMS, INC. | Health Technology |
Private companies | 3 |
---|---|
Enopace Biomedical Ltd.
Enopace Biomedical Ltd. Medical SpecialtiesHealth Technology Enopace Biomedical Ltd. develops medical devices to treat heart failure patients. The firm's technology consists of a minimally invasive, implantable neurostimulation device that increases cardiac efficiency by reducing left ventricular workload and improves the systolic/diastolic ratio. The company was by Yossi Gross and Amir Dagan in 2008 and is headquartered in Caesarea, Israel. | Health Technology |
Qardio, Inc.
Qardio, Inc. Medical DistributorsDistribution Services Qardio, Inc. engages in the provision of wearable applications including heart monitoring devices to track health. It offers healthcare solutions for patients, doctors, and healthcare providers. The company was founded by Marco Peluso and Rosario Iannella in 2012 and is headquartered in San Francisco, CA. | Distribution Services |
Cardiac Rhythm & Heart Failure |
- Stock Market
- Insiders
- David Mark Steinhaus